Lyme disease can be easiest to treat in its earliest stages, but current tests often miss infections during that critical window and cannot tell whether bacteria are still present or were cleared years ago. New research led by Tufts University School of Medicine suggests that a group of immune molecules called anti-lipid antibodies may address these shortcomings.

What do laparoscopic surgery and robotic lunar construction have in common? Plenty, as it turns out, for Shuai Li, Ph.D., associate professor in the University of Florida’s Department of Civil & Coastal Engineering.

A breakthrough in the fight against Lyme disease is moving from the laboratory to the hardware store. Researchers at The University of Texas at San Antonio are developing a nontoxic biologic that could soon be available in big-box and home improvement stores.

Type 1 diabetes is widely understood as an autoimmune disease, with the immune system attacking the insulin-producing beta cells of the pancreas. But two new studies suggest those cells may be more than passive victims. Together, the findings indicate that beta cells’ own stress responses and internal defense systems may help shape how the disease begins and progresses.

Better identification and management of sleep apnea and associated vascular risk factors in midlife may provide an important opportunity to support long-term brain health, according to new research from Monash University.